查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2002811

醫用注射射出成型塑膠市場：2026-2032年全球市場預測（依產品類型、材料類型、應用、製造流程和無菌要求分類）

Medical Injection Molded Plastics Market by Product Type, Material Type, End Use, Process Type, Sterility Requirement - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用射出成型塑膠市場價值將達到 662.4 億美元，到 2026 年將成長至 715 億美元，到 2032 年將達到 1,206.8 億美元，複合年成長率為 8.94%。

主要市場統計數據
基準年 2025 662.4億美元
預計年份：2026年 715億美元
預測年份 2032 1206.8億美元
複合年成長率 (%) 8.94%

對醫用射出成型塑膠市場進行全面概述，重點在於精密製造、法規遵循和業務永續營運。

醫用射出成型塑膠產業融合了精密工程、嚴格的法規和臨床需求。製造商和供應商必須在複雜的供應商生態系統中游刃有餘，同時還要兼顧材料科學的進步、嚴格的潔淨度標準和不斷發展的醫療設備設計，並積極響應日益成長的患者安全和醫療設備可靠性需求。

技術進步、更嚴格的法規和以患者主導的設計如何影響醫用塑膠的生產要求和競爭優勢？

受技術進步、法規和終端用戶趨勢的驅動，醫用射出成型塑膠產業正經歷著變革性的轉變。聚合物配方和積層製造（AM）相容樹脂的進步，使得生產更輕、更耐用的零件成為可能，並促進了射出成型與微加工技術相結合的混合生產策略的實施。

評估 2025 年美國關稅調整及其對供應鏈結構、材料籌資策略和業務永續營運。

美國於2025年徵收的關稅的累積影響波及整個醫療射出成型供應鏈。在報復性關稅和貿易政策轉變影響原料流通的地區，某些聚合物等級和特殊添加劑的投入成本增加，迫使採購團隊重新評估籌資策略和供應商選擇。

透過對產品、材料、最終用途、製程和無菌性等維度進行綜合細分分析，可以揭示技術重點和商業化限制。

市場區隔洞察揭示了產品、材料、最終用途、製程和無菌要求等方面的技術複雜性與商業性機會的交會點。按產品類型分類，市場涵蓋診斷組件、給藥系統、輸液器、實驗室設備、手術器械和注射器。診斷組件包括加蓋和加壓蓋、比色皿、微孔盤和微量吸管尖。給藥系統包括自動注射器、吸入器和筆式注射器。輸液器包括延長管、PCA輸液器和標準輸液器。實驗室設備包括燒杯、燒瓶、培養皿和試管。手術器械包括套管、鉗子、鑷子和牽開器。注射器包括預填充式注射器、安全注射器和標準注射器。每類產品都有不同的公差、表面光潔度和可追溯性要求，而給藥裝置和手術器械通常需要更高的尺寸控制和無菌保證。

影響製造地和打入市場策略的美洲、歐洲、中東和非洲以及亞太地區的區域生產和監管趨勢。

在美洲、歐洲、中東和非洲以及亞太地區，區域趨勢正在影響生產基地選擇、供應商選擇和監管合規的策略決策。在美洲，接近性關鍵醫療系統和擁有快速反應的物流基礎設施仍然至關重要，這促使企業投資建設本地生產基地並進行國內驗證，以支持對時間要求嚴格的產品上市。

在醫用塑膠領域，企業間的策略性投資、夥伴關係和能力差異化如何決定競爭地位和供應可靠性？

射出成型醫用塑膠產業的企業策略體現了能力建構、垂直整合和策略夥伴關係之間的平衡。領先的製造商在無塵室基礎設施、精密模具和線上檢測系統方面投入巨資，以滿足複雜的產品組裝和嚴格的無菌要求。同時，小規模的專業公司則透過提供微成型技術和快速原型製作，為早期醫療設備開發開拓利基市場。

產業領導者為加強醫療設備組件的供應韌性、加快驗證速度和提高製造彈性所提出的實際策略重點。

產業領導者應優先投資於能夠增強供應鏈韌性、縮短驗證週期並提高生產柔軟性。關鍵聚合物供應商多元化以及確保區域樹脂緩衝供應可以減輕貿易中斷的影響。此外，對替代材料進行並行認證可以為設計團隊提供應急方案，而不會影響設備性能。

結合專家訪談、實地檢驗審查和文獻整合的穩健混合研究途徑，確保了可操作和可靠的見解。

本分析的調查方法結合了對技術文獻、監管指南和行業最佳實踐的系統性回顧，以及定性訪談和現場觀察。主要資訊來源包括對製造工程師、品質經理和採購主管的專家訪談，以及工廠現場考察和驗證通訊協定審查，以評估實際實施中面臨的挑戰。

整合策略挑戰，強調為什麼對材料、過程控制和供應商韌性的投資對於長期競爭力至關重要。

醫療射出成型塑膠產業面臨著技術日益複雜、監管力度不斷加強以及供應鏈形勢瞬息萬變等諸多挑戰——所有這些因素都要求企業採取謹慎的策略行動。投資於材料合格流程、無塵室設施和數位化流程控制的企業，將更有能力應對以病人主導的設計趨勢和日益嚴格的驗證要求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫用射出成型塑膠市場：依產品類型分類

  • 診斷組件
    • 封頂尖峰帽
    • 庫維特
    • 微孔盤
    • 微量吸管尖
  • 藥物輸送系統
    • 自動注射器
    • 吸入器
    • 筆式注射器
  • 點滴器
    • 擴充集
    • PCA套裝
    • 標準靜脈輸液套裝
  • 實驗室設備
    • 燒杯
    • 燒瓶
    • 培養皿
    • 試管
  • 手術器械
    • 套管
    • 夾鉗
    • 鉗子
    • 牽開器
  • 注射器
    • 預填充式注射器
    • 安全注射器
    • 標準注射器

第9章 醫用射出成型塑膠市場：依材料類型分類

  • ABS
  • 聚碳酸酯
  • 聚乙烯
    • HDPE
    • LDPE
  • 聚丙烯
  • 聚苯乙烯

第10章 醫用射出成型塑膠市場：依最終用途分類

  • 診所
  • 診斷檢查室
  • 居家醫療
  • 醫院
  • 製藥公司

第11章：依工藝分類的醫用射出成型塑膠市場

  • 潔淨室模具
    • 七年級
    • 八年級
  • 傳統射出成型
  • 微型射出成型
  • 多色射出成型

第12章：依滅菌要求分類的醫用射出成型塑膠市場

  • 非無菌部件
  • 無菌部件

第13章 醫用射出成型塑膠市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫用射出成型塑膠市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 醫用射出成型塑膠市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫用射出成型塑膠市場

第17章：中國醫用射出成型塑膠市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AMS Micromedical LLC
  • AptarGroup, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Berry Global, Inc.
  • C&J Industries, Inc.
  • Currier Plastics, Inc.
  • Engel Austria GmbH
  • Freudenberg Medical LLC
  • Gerresheimer AG
  • Harbec, Inc.
  • HTI Plastics
  • Jabil Healthcare
  • MedPlast, Inc.
  • Metro Mold & Design, Inc.
  • Milacron Holdings Corp.
  • Nipro Corporation
  • Rochling SE & Co. KG
  • SCHOTT AG
  • SMC Ltd.
  • Spectrum Plastics Group, Inc.
  • Stevanato Group SpA
  • Tekni-Plex, Inc.
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.
Product Code: MRR-7C50F2739303

The Medical Injection Molded Plastics Market was valued at USD 66.24 billion in 2025 and is projected to grow to USD 71.50 billion in 2026, with a CAGR of 8.94%, reaching USD 120.68 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 66.24 billion
Estimated Year [2026] USD 71.50 billion
Forecast Year [2032] USD 120.68 billion
CAGR (%) 8.94%

A comprehensive orientation to the medical injection-molded plastics landscape emphasizing precision manufacturing, regulatory compliance, and operational resilience

The medical injection-molded plastics sector operates at the intersection of precision engineering, regulatory rigor, and clinical necessity. Manufacturers and suppliers must reconcile material science advances with stringent cleanliness standards and evolving device designs, while navigating complex supplier ecosystems and increasing emphasis on patient safety and device reliability.

Recent years have seen intensified attention on process repeatability, material traceability, and sterility management, prompting stakeholders to reassess capital deployment, quality systems, and strategic partnerships. As companies innovate across product portfolios, they must also balance speed-to-market with validation burdens, making operational excellence and regulatory foresight central to sustained competitiveness.

How converging technological advances, regulatory tightening, and patient-driven design are reshaping production imperatives and competitive advantage in medical plastics

The landscape for injection-molded medical plastics is undergoing transformative shifts driven by technological, regulatory, and end-user trends. Advances in polymer formulations and additive manufacturing-compatible resins are enabling lighter, more durable components and facilitating hybrid production strategies that blend injection molding with microfabrication techniques.

Concurrently, regulatory authorities are tightening device validation pathways and demanding greater supply chain transparency, which in turn elevates the importance of cleanroom capabilities and validated sterilization workflows. Patient-centric design is reshaping product specifications, pushing manufacturers toward modular drug delivery systems and integrated diagnostics that require higher dimensional accuracy and biocompatibility. These converging changes necessitate investments in automation, in-line inspection, and data-driven process control to maintain throughput while ensuring consistent quality.

Assessment of the 2025 United States tariff adjustments and their cascading effects on supply chain configurations, material sourcing strategies, and operational resilience

The cumulative effects of tariffs introduced by the United States in 2025 ripple across the supply chains that underpin medical injection molding. Input costs for certain polymer grades and specialized additives rose in jurisdictions where reciprocal tariffs and trade policy shifts affected raw material flows, prompting procurement teams to re-evaluate sourcing strategies and vendor footprints.

In response, some manufacturers accelerated supplier diversification and nearshoring initiatives, investing in regional resin inventories and alternative material qualification programs to mitigate single-source exposure. These adjustments introduced short-term operational overheads but also stimulated longer-term reconfiguration of logistics and inventory strategies, the outcome of which has been greater emphasis on supplier resilience and localized validation capabilities to preserve regulatory compliance while stabilizing production costs.

Integrated segmentation analysis across product, material, end-use, process, and sterility axes to reveal technical priorities and commercialization constraints

Segmentation insights reveal where technical complexity and commercial opportunity intersect across product, material, end use, process, and sterility requirements. Based on Product Type, the market encompasses Diagnostic Components, Drug Delivery Systems, Infusion Sets, Labware, Surgical Instruments, and Syringes; Diagnostic Components further include Capping Spiking Caps, Cuvettes, Microplates, and Pipette Tips; Drug Delivery Systems further include Autoinjectors, Inhalers, and Pen Injectors; Infusion Sets further include Extension Sets, Pca Sets, and Standard Infusion Sets; Labware further includes Beakers, Flasks, Petri Dishes, and Test Tubes; Surgical Instruments further include Cannulas, Clamps, Forceps, and Retractors; Syringes further include Prefilled Syringes, Safety Syringes, and Standard Syringes. Each product cluster imposes distinct tolerances, surface finishes, and traceability requirements, with drug delivery devices and surgical instruments typically demanding higher levels of dimensional control and sterility assurance.

Based on Material Type, critical polymers include ABS, Polycarbonate, Polyethylene, Polypropylene, and Polystyrene, with Polyethylene further differentiated into HDPE and LDPE. Material selection drives decisions around sterilization compatibility, biocompatibility testing, and long-term stability, while also determining tool wear and cycle times. Based on End Use, components serve Clinics, Diagnostic Labs, Home Healthcare settings, Hospitals, and Pharmaceutical Companies, and each end-use environment imposes unique packaging, labeling, and usability constraints that influence design and process choices. Based on Process Type, production techniques range from Cleanroom Molding, Conventional Injection Molding, Micro Injection Molding, to Multi-Shot Injection Molding, with Cleanroom Molding further classified into Class 7 and Class 8 environments; process choice affects contamination risk, inspection regimes, and cleanroom utilities. Finally, based on Sterility Requirement, differentiation between Non-Sterile Components and Sterile Components informs material handling, validation depth, and post-molding sterilization workflow design.

Taken together, these segmentation layers illustrate that cross-functional coordination between design engineering, materials science, and quality assurance is essential. Manufacturers must align polymer selection with molding capabilities and end-use demands while ensuring that process classification and sterility pathways are validated early in development to avoid rework and regulatory delays.

Regional production and regulatory dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence manufacturing footprint and market access strategies

Regional dynamics shape strategic choices for production location, supplier selection, and regulatory navigation across the Americas, Europe, Middle East & Africa, and Asia-Pacific. The Americas region continues to emphasize proximity to major healthcare systems and rapid response logistics, driving investments in localized manufacturing cells and onshore validation to support time-sensitive product launches.

In Europe, Middle East & Africa, regulatory harmonization and diverse market access requirements necessitate robust compliance frameworks and adaptable distribution models, with manufacturers prioritizing certifications and multilingual packaging. The Asia-Pacific region remains a pivotal source of polymer feedstocks and scale manufacturing capacity, prompting many organizations to maintain dual-location strategies that balance cost efficiency with redundancy. Collectively, these regional considerations underscore the importance of aligning manufacturing footprints with regulatory timelines, clinical trial schedules, and customer service expectations.

How strategic investments, partnerships, and capability differentiation among companies determine competitive positioning and supply reliability in the medical plastics domain

Company strategies in the injection-molded medical plastics space reflect a balance between capability development, vertical integration, and strategic partnerships. Market-leading manufacturers invest heavily in cleanroom infrastructure, precision tooling, and in-line inspection systems to support complex product assemblies and stringent sterility requirements, while smaller specialized firms carve niches by offering micro-molding expertise or rapid prototyping for early-stage device development.

Collaborative relationships between polymer suppliers, contract manufacturers, and device OEMs are increasingly common as organizations seek to compress development timelines and mitigate validation risks. Joint development agreements and co-investment in tooling or process automation are typical approaches to share capital risk and accelerate time-to-clinic. Additionally, quality certifications, audit track records, and the ability to provide comprehensive design-for-manufacturability feedback are among the primary differentiators that procurement teams evaluate when selecting partners.

Actionable strategic priorities for industry leaders to enhance supply resilience, accelerate validation, and improve manufacturing agility for medical device components

Industry leaders should prioritize investments that strengthen supply chain resilience, reduce validation cycle times, and increase manufacturing flexibility. Enhancing supplier diversification for critical polymers and establishing regional resin buffers can lower exposure to trade disruptions, while parallel qualification of alternative materials can provide design teams with contingency options without compromising device performance.

Operational improvements such as adopting in-line inspection, statistical process control, and automated documentation systems will compress time-to-release and reduce human error. Leaders should also evaluate opportunities to modularize product designs for easier assembly and sterilization, and to invest in cross-functional teams that integrate regulatory, quality, and manufacturing expertise early in development to avoid late-stage changes that are costly and time-consuming.

Robust mixed-methods research approach combining expert interviews, on-site validation reviews, and literature synthesis to ensure actionable and reliable insights

The research methodology underpinning this analysis combined a structured review of technical literature, regulatory guidance, and industry best practices with qualitative interviews and site-level observations. Primary inputs included expert interviews with manufacturing engineers, quality leaders, and procurement executives, supplemented by factory-floor walkthroughs and validation protocol reviews to assess practical implementation challenges.

Secondary inputs comprised peer-reviewed materials science publications, standards documentation, and publicly available regulatory notices that informed the interpretation of sterility, biocompatibility, and cleanroom requirements. Where possible, triangulation across multiple independent sources was used to corroborate observations and minimize single-source bias, and findings were synthesized to emphasize operational applicability and risk mitigation strategies for stakeholders.

Synthesis of strategic imperatives highlighting why investment in materials, process control, and supplier resilience is essential for long-term competitiveness

The medical injection-molded plastics sector is characterized by accelerating technical complexity, heightened regulatory scrutiny, and evolving supply chain realities that together demand deliberate strategic action. Organizations that invest in material qualification pathways, cleanroom capabilities, and digital process control will be better positioned to respond to patient-driven design trends and tighter validation expectations.

Moving forward, successful participants will be those that integrate cross-functional teams early in the development lifecycle, prioritize supplier resilience, and adopt targeted automation that enhances repeatability without sacrificing flexibility. By aligning technical investments with regulatory and regional market realities, manufacturers can convert current challenges into competitive advantage and sustainably support the healthcare products that depend on precision polymer components.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Injection Molded Plastics Market, by Product Type

  • 8.1. Diagnostic Components
    • 8.1.1. Capping Spiking Caps
    • 8.1.2. Cuvettes
    • 8.1.3. Microplates
    • 8.1.4. Pipette Tips
  • 8.2. Drug Delivery Systems
    • 8.2.1. Autoinjectors
    • 8.2.2. Inhalers
    • 8.2.3. Pen Injectors
  • 8.3. Infusion Sets
    • 8.3.1. Extension Sets
    • 8.3.2. Pca Sets
    • 8.3.3. Standard Infusion Sets
  • 8.4. Labware
    • 8.4.1. Beakers
    • 8.4.2. Flasks
    • 8.4.3. Petri Dishes
    • 8.4.4. Test Tubes
  • 8.5. Surgical Instruments
    • 8.5.1. Cannulas
    • 8.5.2. Clamps
    • 8.5.3. Forceps
    • 8.5.4. Retractors
  • 8.6. Syringes
    • 8.6.1. Prefilled Syringes
    • 8.6.2. Safety Syringes
    • 8.6.3. Standard Syringes

9. Medical Injection Molded Plastics Market, by Material Type

  • 9.1. Abs
  • 9.2. Polycarbonate
  • 9.3. Polyethylene
    • 9.3.1. Hdpe
    • 9.3.2. Ldpe
  • 9.4. Polypropylene
  • 9.5. Polystyrene

10. Medical Injection Molded Plastics Market, by End Use

  • 10.1. Clinic
  • 10.2. Diagnostic Labs
  • 10.3. Home Healthcare
  • 10.4. Hospitals
  • 10.5. Pharmaceutical Companies

11. Medical Injection Molded Plastics Market, by Process Type

  • 11.1. Cleanroom Molding
    • 11.1.1. Class 7
    • 11.1.2. Class 8
  • 11.2. Conventional Injection Molding
  • 11.3. Micro Injection Molding
  • 11.4. Multi-Shot Injection Molding

12. Medical Injection Molded Plastics Market, by Sterility Requirement

  • 12.1. Non-Sterile Components
  • 12.2. Sterile Components

13. Medical Injection Molded Plastics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Injection Molded Plastics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Injection Molded Plastics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Injection Molded Plastics Market

17. China Medical Injection Molded Plastics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AMS Micromedical LLC
  • 18.6. AptarGroup, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Becton, Dickinson and Company
  • 18.9. Berry Global, Inc.
  • 18.10. C&J Industries, Inc.
  • 18.11. Currier Plastics, Inc.
  • 18.12. Engel Austria GmbH
  • 18.13. Freudenberg Medical LLC
  • 18.14. Gerresheimer AG
  • 18.15. Harbec, Inc.
  • 18.16. HTI Plastics
  • 18.17. Jabil Healthcare
  • 18.18. MedPlast, Inc.
  • 18.19. Metro Mold & Design, Inc.
  • 18.20. Milacron Holdings Corp.
  • 18.21. Nipro Corporation
  • 18.22. Rochling SE & Co. KG
  • 18.23. SCHOTT AG
  • 18.24. SMC Ltd.
  • 18.25. Spectrum Plastics Group, Inc.
  • 18.26. Stevanato Group S.p.A.
  • 18.27. Tekni-Plex, Inc.
  • 18.28. Terumo Corporation
  • 18.29. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CAPPING SPIKING CAPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CAPPING SPIKING CAPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CAPPING SPIKING CAPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CUVETTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CUVETTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CUVETTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICROPLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICROPLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PIPETTE TIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PIPETTE TIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PIPETTE TIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY AUTOINJECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY AUTOINJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INHALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INHALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PEN INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PEN INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY EXTENSION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY EXTENSION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY EXTENSION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PCA SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PCA SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PCA SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD INFUSION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD INFUSION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD INFUSION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY BEAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY BEAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY BEAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FLASKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FLASKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FLASKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PETRI DISHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PETRI DISHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PETRI DISHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY TEST TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY TEST TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY TEST TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CANNULAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CANNULAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CANNULAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLAMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLAMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLAMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FORCEPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FORCEPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FORCEPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY RETRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SAFETY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SAFETY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY ABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY ABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY ABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HDPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HDPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HDPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LDPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LDPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LDPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYSTYRENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYSTYRENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYSTYRENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 7, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 7, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 7, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 8, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 8, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 8, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CONVENTIONAL INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CONVENTIONAL INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CONVENTIONAL INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICRO INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICRO INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICRO INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MULTI-SHOT INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MULTI-SHOT INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MULTI-SHOT INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY NON-STERILE COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY NON-STERILE COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY NON-STERILE COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILE COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILE COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILE COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 284. GCC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. GCC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. GCC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS